Credit Suisse Ag Zymeworks Inc. Transaction History

Credit Suisse Ag

13 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2022 Nov 10, 2022	SELL	$4.65 - $7.43 $12,206 - $19,503	-2,625 Reduced 0.11%	2,440,372 $15 Million
Q2 2022 Aug 12, 2022	SELL	$4.82 - $7.7 $154,264 - $246,438	-32,005 Reduced 1.29%	2,442,997 $12.9 Million
Q1 2022 May 16, 2022	BUY	$6.0 - $16.98 $66,162 - $187,238	11,027 Added 0.45%	2,475,002 $16.2 Million
Q4 2021 Feb 14, 2022	BUY	$15.19 - $29.33 $1.78 Million - $3.45 Million	117,457 Added 5.01%	2,463,975 $40.4 Million
Q3 2021 Nov 12, 2021	BUY	$27.35 - $37.28 $4,321 - $5,890	158 Added 0.01%	2,346,518 $68.1 Million
Q2 2021 Aug 16, 2021	BUY	$26.5 - $38.23 $1.45 Million - $2.1 Million	54,871 Added 2.39%	2,346,360 $84.2 Million
Q1 2021 May 14, 2021	BUY	$29.83 - $56.81 $13.7 Million - $26.1 Million	459,928 Added 25.11%	2,291,489 $72.4 Million
Q4 2020 Feb 12, 2021	BUY	$39.12 - $54.99 $4.41 Million - $6.21 Million	112,843 Added 6.57%	1,831,561 $86.6 Million
Q3 2020 Nov 13, 2020	BUY	$29.21 - $46.58 $11.7 Million - $18.7 Million	400,632 Added 30.39%	1,718,718 $80.1 Million
Q2 2020 Aug 12, 2020	BUY	$33.67 - $40.0 $13.9 Million - $16.5 Million	413,080 Added 45.64%	1,318,086 $47.5 Million
Q1 2020 May 13, 2020	BUY	$24.28 - $49.8 $19.8 Million - $40.5 Million	814,101 Added 895.55%	905,006 $32.1 Million
Q4 2019 Feb 12, 2020	BUY	$24.84 - $45.46 $1.84 Million - $3.36 Million	74,007 Added 437.96%	90,905 $4.13 Million
Q3 2019 Nov 12, 2019	BUY	$22.78 - $29.08 $384,936 - $491,393	16,898 New	16,898 $419,000

296K

Ticker ZYME
Exchange NYSE
Sector Healthcare
Industry Biotechnology
Shares Outstandng 61,694,400
Market Cap $872M
Description
Zymeworks Inc., a clinical-stage biopharmaceutical company, discovers, develops, and commercializes biotherapeutics for the treatment of cancer. The company's lead product candidates include zanidatamab, a novel bispecific antibody that is in Phase 1 and Phase 2 clinical trials for the treatment of biliary tract, gastroesophageal adenocarcinomas...

Get notified when there are updates to the investment portfolio of Credit Suisse Ag, based on Form 13F filings with the SEC.

Stay updated on Credit Suisse Ag with notifications on news.